This led to further immunohistochemical testing on the previously obtained muscle biopsy specimen from our patient that demonstrated an absence of dysferlin staining, thus establishing the diagnosis of dysferlinopathy (LGMD2B). The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.